IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target -February 23, 2024 at 12:02 pm EST
IGC Pharma, Inc. announces that Ascendiant Capital Markets LLC has issued an analyst coverage research report on the Company’s common stock. All reports on IGC Pharma prepared by analysts...